June 14, 2013

9:31a
Critical Alerts For Anheuser-Busch InBev, GlaxoSmithKline, Capital One, Safeway, and Onyx Pharmaceuticals Released By InvestorsObserver   (PR NewsWire)
8:00a
Ongoing Clinical Trials Reveal Groundbreaking Results - Research Report on Alexion, BioMarin, Onyx, Questcor, and ImmunoGen   (PR NewsWire)

June 6, 2013

4:00p
Onyx Pharmaceuticals to Present at Upcoming Investor Conferences   (Market Wire)

June 4, 2013

12:00a
Positive Data on Bayer/Onyx's Nexavar - Analyst Blog   (Zacks.com)

June 3, 2013

8:00a
Onyx Pharmaceuticals and the UCSF Helen Diller Family Comprehensive Cancer Center Announce Oncology Innovation Alliance   (Market Wire)

June 2, 2013

7:30a
Phase 3 DECISION Trial Investigating the Use of Nexavar® (sorafenib) Demonstrated Significant Improvement in Progression-Free Survival in Patients with Radioactive Iodine-Refractory Differentiated Thyroid Cancer   (PR NewsWire)

May 31, 2013

4:00p
Onyx Pharmaceuticals Announces Conference Call to Discuss Phase 3 DECISION Data at 2013 ASCO Annual Meeting   (Market Wire)

May 21, 2013

4:00p
Onyx Pharmaceuticals Announces Data Presentations at the 18th Congress of the European Hematology Association   (Market Wire)

May 15, 2013

6:00p
Onyx Pharmaceuticals Announces Data Presentations at 49th American Society of Clinical Oncology Annual Meeting   (Market Wire)

May 14, 2013

10:05a
In Relapsed/Refractory Multiple Myeloma, Thought Leaders Are Optimistic that the Combination of Carfilzomib, Lenalidomide and Dexamethasone Will Be the Most Efficacious Regimen   (PR NewsWire)
9:55a
Wider-than-Expected Loss at ChemoCentryx - Analyst Blog   (Zacks.com)

May 9, 2013

3:53p
Good News for Cubist Pharmaceuticals - Analyst Blog   (Zacks.com)
1:05p
Narrower-than-Expected Loss at ArQule - Analyst Blog   (Zacks.com)

May 8, 2013

5:32p
Narrower Loss from Onyx, Guidance Maintained - Analyst Blog   (Zacks.com)
4:00p
Onyx Pharmaceuticals to Present at Upcoming Investor Conferences   (Market Wire)
11:10a
ONXY Pharmaceuticals (ONXX) $95.73 up $5.18...   (S&P Capital IQ)
10:37a
S&P MAINTAINS BUY OPINION ON SHARES OF ONYX PHARMACEUTICALS   (S&P Capital IQ)

May 7, 2013

4:00p
Onyx Pharmaceuticals Reports First Quarter 2013 Financial Results   (Market Wire)
11:40a
Wider-than-Expected Loss at Corcept - Analyst Blog   (Zacks.com)
8:27a
Valeant Misses Earnings and Revenue Estimate in 1Q (Revised) - Analyst Blog   (Zacks.com)

May 6, 2013

4:30p
Positive Opinion on Allergan Candidate - Analyst Blog   (Zacks.com)
3:30p
Perrigo Likely to Report In Line Earnings - Analyst Blog   (Zacks.com)
12:38p
Narrower-than-Expected Loss at Cadence - Analyst Blog   (Zacks.com)

May 3, 2013

2:16p
Questcor Misses on Earnings, Revs - Analyst Blog   (Zacks.com)
1:05p
Valeant Beats Earnings, Misses Revs - Analyst Blog   (Zacks.com)
12:54p
Shire Beats Earnings in 1Q - Analyst Blog   (Zacks.com)

May 2, 2013

1:09p
ViroPharma Reports Loss in 1Q - Analyst Blog   (Zacks.com)

May 1, 2013

12:03p
Allergan Beats on Earnings - Analyst Blog   (Zacks.com)
10:31a
Positive CHMP Opinion for Avanir - Analyst Blog   (Zacks.com)

April 30, 2013

12:46p
Wider Loss at Auxilium, Acquires Actient - Analyst Blog   (Zacks.com)

April 26, 2013

11:42a
Earnings Beat for AbbVie - Analyst Blog   (Zacks.com)

April 25, 2013

11:00a
UCB Sales Drop in 1Q - Analyst Blog   (Zacks.com)

April 24, 2013

8:24a
Lilly Earnings Better Than Expected - Analyst Blog   (Zacks.com)

April 16, 2013

4:00p
Onyx Pharmaceuticals to Report First Quarter 2013 Financial Results After Market on May 7, 2013   (Market Wire)

April 15, 2013

4:30p
Will JNJ Miss on Earnings? - Analyst Blog   (Zacks.com)
Go to All Current & Historical News